Landec Corporation Schedules First Quarter 2014 Earnings Release for September 24, 2013 and Conference Call for September 25,

Landec Corporation Schedules First Quarter 2014 Earnings Release for September
24, 2013 and Conference Call for September 25, 2013

MENLO PARK, Calif., Sept. 3, 2013 (GLOBE NEWSWIRE) -- Landec Corporation
(Nasdaq:LNDC) announced today that it will report financial results for the
fiscal year 2014 first quarter ended August 25, 2013, after market close on
September 24, 2013.

The news release will be followed the next morning, Wednesday, September 25,
2013, by a teleconference and webcast open to all interested parties at 8:00
a.m., Pacific Time. The teleconference can be accessed by calling 866-793-1301
or 703-639-1307. Please log in 5-10 minutes prior to the beginning of the
call.

This call is being webcast and can be accessed on Landec's web site at
www.Landec.com/earningscall. The webcast will be available for 30 days through
October 25, 2013. A replay of the teleconference will be available for one
week until midnight Eastern Time, Wednesday, October 2, 2013, by calling
888-266-2081 or 703-925-2533. The access code for the replay is 1621865.

For further information, please call Greg Skinner (650) 261-3677.

Landec Corporation is a materials science company that leverages its
proprietary polymer technologies, application development and innovation
capabilities to develop and commercialize new products in food and
biomaterials markets. Landec's subsidiary, Apio, has become the leader in US
fresh-cut specialty packaged vegetables sold in North America based on
combining Landec's proprietary food packaging technology and the strength of
two major national brands, Eat Smart® and GreenLine®, with the capabilities of
large scale processing and national distribution. Lifecore Biomedical, a
subsidiary of Landec, is a premium supplier of hyaluronan-based materials and
medical products to ophthalmic, orthopedic and veterinary markets worldwide.
In addition, Lifecore Biomedical provides specialized aseptic fill and finish
services in a cGMP validated manufacturing facility for supplying commercial,
clinical and pre-clinical products. Landec will also periodically work with
market-leading companies to develop and commercialize differentiated
polymer-based products under R&D and royalty agreements. For more information
about the Company, visit Landec's website at www.landec.com.

CONTACT: Landec Corporation
         Greg Skinner
         650-261-3677
        
         Investor Relations Contact:
         Liolios Group, Inc.
         Justin Vaicek
         949-574-3860
         LNDC@liolios.com

company logo
 
Press spacebar to pause and continue. Press esc to stop.